Clinical Trial Update: A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating bone turnover markers in treatment-naive postmenopausal osteoporosis patients treated with ibandronate (Boniva); results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Boniva (ibandronate)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Post Menopausal Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2016-03-09